Effect of some phosphodiesterase inhibitors on adenylate cyclase from the liver fluke, Fasciola hepatica.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D004974:Etazolate / Q000494:pharmacology; D005210:Fasciola hepatica / Q000187:drug effects / Q000201:enzymology*; D006160:Guanosine Triphosphate / Q000494:pharmacology; D007700:Kinetics; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D010726:Phosphodiesterase Inhibitors; D011799:Quinazolines; D012701:Serotonin; D006160:Guanosine Triphosphate; D010208:Papaverine; D000262:Adenylyl Cyclases; D004974:Etazolate; D015056:1-Methyl-3-isobutylxanthine